BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1164 related articles for article (PubMed ID: 24946958)

  • 61. Radiofrequency ablation of incidental benign small renal mass: outcomes and follow-up protocol.
    Tan YK; Best SL; Olweny E; Park S; Trimmer C; Cadeddu JA
    Urology; 2012 Apr; 79(4):827-30. PubMed ID: 22309782
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Kidney neoplasms: renal halo sign after percutaneous radiofrequency ablation--incidence and clinical importance in 101 consecutive patients.
    Schirmang TC; Mayo-Smith WW; Dupuy DE; Beland MD; Grand DJ
    Radiology; 2009 Oct; 253(1):263-9. PubMed ID: 19703853
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
    De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
    Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Percutaneous radio frequency ablation of renal masses: results at a 2-year mean followup.
    Varkarakis IM; Allaf ME; Inagaki T; Bhayani SB; Chan DY; Su LM; Jarrett TW; Kavoussi LR; Solomon SB
    J Urol; 2005 Aug; 174(2):456-60; discussion 460. PubMed ID: 16006864
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Percutaneous imaging-guided radiofrequency ablation of small renal cell carcinoma: techniques and outcomes of 24 treatment sessions in 18 consecutive patients.
    Popovic P; Surlan-Popovic K; Lukic S; Mijailovic M; Jankovic S; Kuhelj D
    J BUON; 2011; 16(1):127-32. PubMed ID: 21674863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB; Pilgram TK; Brown DB
    J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improved outcome with combined US/CT guidance as compared to US guidance in percutaneous radiofrequency ablation of small renal masses.
    Andersson M; Hashimi F; Lyrdal D; Lundstam S; Hellström M
    Acta Radiol; 2015 Dec; 56(12):1519-26. PubMed ID: 25414370
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Radiofrequency ablation of renal cell carcinoma: a follow up of outcomes.
    Curry D; Yassin M; Thwaini A; Pahuja A; Alanbuki AH; Rajan TN; Loan W
    Can J Urol; 2014 Feb; 21(1):7135-40. PubMed ID: 24529016
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acute histologic effects of temperature-based radiofrequency ablation on renal tumor pathologic interpretation.
    Margulis V; Matsumoto ED; Lindberg G; Tunc L; Taylor G; Sagalowsky AI; Cadeddu JA
    Urology; 2004 Oct; 64(4):660-3. PubMed ID: 15491694
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Predictive factors for complete renal tumor ablation using RFA.
    Acosta Ruiz V; Lönnemark M; Brekkan E; Dahlman P; Wernroth L; Magnusson A
    Acta Radiol; 2016 Jul; 57(7):886-93. PubMed ID: 26452975
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Imaging-guided radiofrequency ablation of cystic renal neoplasms.
    Allen BC; Chen MY; Childs DD; Zagoria RJ
    AJR Am J Roentgenol; 2013 Jun; 200(6):1365-9. PubMed ID: 23701077
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Assessment of health-related quality of life after radiofrequency ablation or laparoscopic surgery for small renal cell carcinoma: a prospective study with medical outcomes Study 36-Item Health Survey (SF-36).
    Onishi T; Nishikawa K; Hasegawa Y; Yamada Y; Soga N; Arima K; Yamakado K; Hoshina A; Sugimura Y
    Jpn J Clin Oncol; 2007 Oct; 37(10):750-4. PubMed ID: 17942577
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Oncological and Functional Outcomes of Laparoscopic Radiofrequency Ablation and Partial Nephrectomy for T1a Renal Masses: A Retrospective Single-center 60 Month Follow-up Cohort Study.
    Park JM; Yang SW; Shin JH; Na YG; Song KH; Lim JS
    Urol J; 2019 Feb; 16(1):44-49. PubMed ID: 30120758
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term results after computed-tomography-guided percutaneous radiofrequency ablation for small renal tumors.
    Ferakis N; Bouropoulos C; Granitsas T; Mylona S; Poulias I
    J Endourol; 2010 Dec; 24(12):1909-13. PubMed ID: 20946062
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Results of computerized tomography guided percutaneous ablation of renal masses with nondiagnostic pre-ablation pathological findings.
    Permpongkosol S; Link RE; Solomon SB; Kavoussi LR
    J Urol; 2006 Aug; 176(2):463-7; discussion 467. PubMed ID: 16813865
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radiofrequency ablation versus radical nephrectomy: clinical outcomes for stage T1b renal cell carcinoma.
    Takaki H; Soga N; Kanda H; Nakatsuka A; Uraki J; Fujimori M; Yamanaka T; Hasegawa T; Arima K; Sugimura Y; Sakuma H; Yamakado K
    Radiology; 2014 Jan; 270(1):292-9. PubMed ID: 23925272
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Percutaneous Ablation Versus Nephrectomy for Small Renal Masses: Clinical Outcomes in a Single-Center Cohort.
    Lourenco P; Bilbey N; Gong B; Bahrabadi A; Halkier B
    Cardiovasc Intervent Radiol; 2018 Dec; 41(12):1892-1900. PubMed ID: 30088062
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Percutaneous CT-guided radiofrequency ablation for small renal masses : A retrospective, single center data analysis].
    Heißler O; Seklehner S; Fellner H; Engelhardt PF; Chemelli A; Riedl C
    Urologe A; 2018 Jul; 57(7):828-835. PubMed ID: 29797025
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Percutaneous Clinical T1a Renal Mass Ablation in the Octogenarian and Nonagenarian: Oncologic Outcomes and Morbidity.
    Miller AJ; Kurup AN; Schmit GD; Weisbrod AJ; Boorjian SA; Thompson RH; Lohse CM; Kor DJ; Callstrom MR; Atwell TD
    J Endourol; 2015 Jun; 29(6):671-6. PubMed ID: 25386995
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety, efficacy and predictors of local recurrence after percutaneous radiofrequency ablation of biopsy-proven renal cell carcinoma.
    Su MZ; Memon F; Lau HM; Brooks AJ; Patel MI; Woo HH; Bariol SV; Vladica P
    Int Urol Nephrol; 2016 Oct; 48(10):1609-16. PubMed ID: 27432413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.